1. Despite the good long-term outcome for anterior temporal lobectomy seen in patients with hippocampal sclerosis (sustained seizure freedom with or without simple partial seizures [SPS] of 57% at 5 years and 51% at 10 years), there remains substantial room for improvement. Comment: This finding is similar to prior studies (Table 1 ; [3, 4] ) once it is recognized that this study looks at sustained seizure freedom throughout the follow-up period, not just seizure freedom for the past 1 to 2 years (as with the commonly used outcome scales). The importance of the outcome scale should not be underestimated; in a large systematic review of long-term outcome after epilepsy surgery (4), the only two multivariate predictors of outcome were year of surgery (worse if prior to 1980) and the outcome scale (better if Engel scale used).
Similarly, for patients with discrete lesions typically
thought to be associated with high seizure-freedom rates, such as cavernous malformations and dysembryoplastic neuroepithelial tumors, 10-year estimated sustained seizure-freedom rates were only 40 to 45 percent. Comment: We should continue to investigate reasons for failure in these groups of patients in detail. Only a prospective multicenter randomized trial of lesionectomy, lesionectomy with electrocorticography, and lesionectomy guided by implantation of intracranial electrodes could determine the best approach to these patients.
3. Seizure freedom at 2 years (with or without auras) was associated with an 80% chance of seizure freedom at 5 years and 72% at 10 years. Comment: This finding is fairly similar to prior studies that reported this type of analysis. Spencer et al. (5) found that if patients were 2 years seizure free, 25% eventually relapsed at some point. McIntosh et al. (6) found that if patients were 2 years seizure free, 86% were seizure free at 5 years and 74% at 10 years. Elsharkawy et al. (7) (N=434 temporal lobe surgeries) found better results: if patients were 2 years seizure free, 95% were seizure free at 5 years, and 92% at 10 years. Cohen-Gadol et al. (8) found that if patients were 1 year seizure free, 92% were seizure free at the 10-year mark.
4. Those with persistent auras were significantly more likely to relapse than those who were completely seizure free. More specifically, if a patient had no seizures at all (including no auras) for the first 2 years, there was an 86% chance that they would still be free of seizures with loss of awareness 5 years later, with a 78% chance 10 years later. In comparison, for those seizure free but with persistent auras in the first 2 years, there was a 67% chance of remaining seizure free 5 years later, with a 55% chance 10 years later. Comment: This finding is similar to prior smaller studies. The only other large study that investigated the prognostic value of persistent auras was The North American Multicenter Study (N = 339) (5), which found that of those free of disabling seizures at 2 years, 32% of those with persistent auras relapsed versus 24% of those without auras (not significant).
5. It was common for patients to move in and out of the seizure-freedom category; this occurred in 3 to 15 percent of patients each year. The same percentage of patients (8%) went from initially seizure free to relapse as did the reverse. At any given time point, about 70% of patients were seizure free (with or without SPS) for the past year, and overall, 82% of patients had at least 1 year free of seizures with loss of awareness.
6. In those who were not seizure free, the chances of becoming seizure free were better than might be expected. For example, for those with persistent seizures at 2 years after surgery, the chance of becoming seizure free for at least one year was 13% 2 years later, 24% 5 years later, and 38% 10 years later.
7. Only a minority (10/47) of delayed relapses could be explained by lowering or withdrawal of medication. Comment: This finding is similar to most but not all prior studies. McIntosh et al. (N = 325) (6) looked at this specifically and found no association of relapse with antiepileptic drug (AED) discontinuation.
8. A significant minority of delayed seizure freedom (>2 years after surgery) was achieved by adding an antiepileptic medication that had not been tried previously; this was most commonly levetiracetam. However, it was more common for delayed seizure freedom to occur without any change in medications.
9. Age at surgery had a small but significant effect: an increase in age of 5 years was associated with a 6% greater risk of seizure recurrence, and an increase of 10 years was associated with a 13% increased risk. Comment: This small but measureable effect of age at surgery on univariate analysis is similar to prior studies (4).
10. Safety was quite good, with 5% of patients having wound infections requiring antibiotics, 3% having CSF leaks requiring repair, <1% with hemiparesis, and 1% with dysphasia.
11. At the latest follow-up, 104 (28%) of 365 seizure-free patients were off medication and therefore "cured" of their epilepsy. Many never attempted to stop medication. Comment: This finding is similar to prior studies. In seizure free patients who attempt AED withdrawal after surgery, 60 to 80 percent of patients remain seizure free (9-11).
12. Of importance, the median duration of epilepsy at time of surgery was 20 years. Comment: This large delay to surgery is remarkably consistent in the literature and has led to multiple official statements on the importance of early referral to specialty centers, typically after failure of two medications or >1 year of seizures.
There are of course some limitations to this study. It spanned multiple decades and is a single-center study; thus it is difficult to know how well it can be extrapolated widely. The determination of seizure freedom or of only SPS was based on patient report, as with virtually all other studies. It is now well known that patient report of seizure frequency or of their maintained awareness is highly inaccurate (12) . There was no evaluation of driving, employment, mood, or overall quality of life. There is an excellent discussion of the prior literature in both the main paper and the accompanying editorial (3). Yet somehow both overlooked the most rigorously performed study on this (5), which included a standardized protocol used at seven centers, prospectively acquired outcome determination every 3 months for a median of 4.6 years, and a similar analysis of late relapses.
In summary, this is a very large, carefully analyzed, and very useful study that will help us counsel patients at various time points before and after epilepsy surgery.
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